In conversation with...

Shankar Siva on radiotherapy for primary renal cell carcinoma

November 28, 2022 The Lancet Oncology
In conversation with...
Shankar Siva on radiotherapy for primary renal cell carcinoma
Show Notes

Shankar Siva (Peter MacCallum Cancer Centre, Melbourne, Australia) discusses his Article on 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma.

Read the full article:
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma